TY - JOUR
T1 - Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly
AU - Rauseo, Adriana M.
AU - Olsen, Margaret A.
AU - Reske, Kimberly A.
AU - Dubberke, Erik R.
N1 - Funding Information:
M Olsen reports consulting work with Pfizer and grants from Sanofi Pasteur, Pfizer and Merck. E Dubberke reports research funding from Pfizer, Synthetic Biologics, Rebiotix and consulting work with Pfizer, Sanofi, Synthetic Biologics, Rebiotix. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Publisher Copyright:
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020/3/3
Y1 - 2020/3/3
N2 - Introduction: Clostridioides difficile remains the most common cause of healthcare-associated infections in the US, and it disproportionately affects the elderly. Older patients are more susceptible and have a greater risk of adverse outcomes from C. difficile infection (CDI), despite advances in treatment and prevention. Areas covered: The epidemiology and pathogenesis of CDI, as well as risk factors in the aging host, will be reviewed. The importance of antimicrobial stewardship and infection prevention in order to avoid acquisition and transmission will be discussed, as well as strategies to prevent adverse outcomes and recurrent CDI, through optimization of CDI treatment s,election. Expert opinion: Appropriate CDI-prevention strategies to avoid adverse outcomes in this susceptible population involve antimicrobial stewardship and methods to prevent C. difficile transmission in healthcare settings. Management strategies to prevent adverse outcomes include initiation of supportive therapy and proper selection of CDI specific treatments. Many patients may also benefit from adjunctive therapies or additional procedures.
AB - Introduction: Clostridioides difficile remains the most common cause of healthcare-associated infections in the US, and it disproportionately affects the elderly. Older patients are more susceptible and have a greater risk of adverse outcomes from C. difficile infection (CDI), despite advances in treatment and prevention. Areas covered: The epidemiology and pathogenesis of CDI, as well as risk factors in the aging host, will be reviewed. The importance of antimicrobial stewardship and infection prevention in order to avoid acquisition and transmission will be discussed, as well as strategies to prevent adverse outcomes and recurrent CDI, through optimization of CDI treatment s,election. Expert opinion: Appropriate CDI-prevention strategies to avoid adverse outcomes in this susceptible population involve antimicrobial stewardship and methods to prevent C. difficile transmission in healthcare settings. Management strategies to prevent adverse outcomes include initiation of supportive therapy and proper selection of CDI specific treatments. Many patients may also benefit from adjunctive therapies or additional procedures.
KW - Adverse outcomes
KW - Clostridioides difficile
KW - antimicrobial stewardship
KW - elderly
KW - infection prevention
UR - http://www.scopus.com/inward/record.url?scp=85078438309&partnerID=8YFLogxK
U2 - 10.1080/14787210.2020.1717950
DO - 10.1080/14787210.2020.1717950
M3 - Review article
C2 - 31976779
AN - SCOPUS:85078438309
SN - 1478-7210
VL - 18
SP - 203
EP - 217
JO - Expert Review of Anti-Infective Therapy
JF - Expert Review of Anti-Infective Therapy
IS - 3
ER -